TABLE 4.
Distribution of MLS types among 82 macrolide-resistant pneumococcal isolates from 11 centers in seven European countries
| MLS typee | Clone designation | No. | % | Predominant countries |
|---|---|---|---|---|
| 81 | Spain23F-1a | 22 | 26.8 | France, Spain, Germany |
| 143 | Pen-R Polish 14 cloneb | 11 | 13.4 | France |
| 156 | Spain9V-3a | 5 | 6.0 | France, Switzerland |
| 658 | New French 14 cloneb | 5 | 6.0 | France |
| 236 | Taiwn19F-14 conea | 4 | 4.9 | Greece |
| 315 | Poland6B-20 clonea,d | 4 | 4.9 | Poland |
| 621 | New French 19F clonec | 4 | 4.9 | France, Switzerland |
| 179 | Spain 19F cloneb | 3 | 3.7 | Switzerland |
| 619 | New French 6B cloneb | 3 | 3.7 | France |
| 620 | New Spanish 6B cloneb | 3 | 3.7 | Spain |
| 15 | SLV of England14-9 clonea,b | 2 | 2.4 | Switzerland |
| 73 | Multiresistant Spanish 15F cloneb | 2 | 2.4 | Portugal, Spain |
| 90 | Spain6B-2 clonea | 2 | 2.4 | Spain |
| 670 | New Swiss 14 cloneb | 2 | 2.4 | Switzerland |
| 9 | England14-9a | 1 | 1.2 | Germany |
| 276 | Netherlands 19 cloneb | 1 | 1.2 | France |
| 564 | German Serotype 14 cloneb | 1 | 1.2 | Germany |
| 699 | New French 23F clone | 1 | 1.2 | France |
| 657 | New French 23F clone | 1 | 1.2 | France |
| Others | New MLST | 5f | 6.0 | Various |
| Total | 82 | 100 |
a
Clones defined by the pneumococcal molecular epidemiology network.
b
For clone definitions, see MLST home page (http://www.mlst.net).
c
Serotype 14 variant of the ST 156 clone, which is generally of serotype 9V.
d
One isolate (13C056) was a serotype 23F.
e
Boldface numbers indicate clones primarily described in the present study.
f
Two isolates (17B044 and 17B047) are atypical pneumococci.